Magnus A O Hook

This inventor holds 11 USPTO granted patents and 1 EPO patent. Top assignees: Texas A&M University System, Bioresearch Ireland, Trinity College Dublin. Active years: 2003-2010.

USPTO Granted Patents = 11

% Patents Active = 45.5

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 124(Granted Patents)

Company Filing History:

9 out of 1,326

Texas A&M University System

Trinity College Dublin

5. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2010

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7855272 - [object Object] (2010-12-21),

2. 7834151 - [object Object] (2010-11-16),

3. 7816494 - [object Object] (2010-10-19),

4. 7709008 - Polypeptides and polynucleotides from coagulase-negative staphylococci (2010-05-04),

5. 7473762 - Proteins and polypeptides from coagulaslase-negative staphylococci (2009-01-06),

6. 7381793 - [object Object] (2008-06-03),

7. 7195763 - Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them (2007-03-27),

8. 6835378 - Method and compositions for inhibiting thrombin-induced coagulation (2004-12-28),

9. 6790448 - Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them (2004-09-14),

10. 6680195 - Extracellular matrix-binding proteins from staphylococcus aureus (2004-01-20),

11. 6635473 - Polypeptides and polynucleotides from coagulase-negative staphylococci (2003-10-21),

Title: Innovations of Magnus A O Hook

Introduction

Magnus A O Hook is a prominent inventor based in Houston, TX (US). He holds a total of 11 patents, showcasing his significant contributions to the field of biomedical research. His work primarily focuses on extracellular matrix-binding proteins, which have important applications in medical treatment and scientific research.

Latest Patents

Among his latest patents, Magnus has developed an isolated extracellular matrix-binding protein designated as SdrE. This protein, along with its corresponding amino acid and nucleic acid sequences, is described as useful for the prevention, inhibition, treatment, and diagnosis of infections. Additionally, it serves as a valuable tool for scientific research. The antibodies or antibody fragments related to SdrE can be administered to wounds or used to coat biomaterials, acting as blocking agents to prevent or inhibit the binding of pathogens. Another significant patent involves an isolated extracellular matrix-binding protein designated as SdrD, which shares similar applications and benefits in the medical field.

Career Highlights

Magnus A O Hook has made notable strides in his career, particularly through his association with The Texas A&M University System. His work has been instrumental in advancing the understanding of extracellular matrix proteins and their applications in healthcare.

Collaborations

Throughout his career, Magnus has collaborated with esteemed colleagues, including Timothy James Foster and Joseph M Patti. These collaborations have further enriched his research and innovation efforts.

Conclusion

Magnus A O Hook's contributions to the field of biomedical research through his patents and collaborations highlight his role as a leading inventor. His work continues to impact the prevention and treatment of infections, showcasing the importance of innovation in healthcare.